US Patent 7759518 Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Patent 7759518 was granted and assigned to Ardea Biosciences, Inc. on July, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+177 characters)
Article
Patent abstract
This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Andreas Maderna0
Dinesh Barawkar0
Hassan el Abdellaoui0
Jean-Michel Vernier0
Varaprasad Chamakura0
Zhi Hong0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07759518 Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK US Patent 7759518 Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Infobox
Patent Number
07759518
Patent Number
7759518
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07759518 Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07759518
Date of patent
July 20, 2010
Patent application number
12323279
Date Filed
November 25, 2008
Patent primary examiner
Find more entities like US Patent 7759518 Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
